Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis

Estarreja, João; Mendes, Priscila; Silva, Carina; Camacho, Pedro; Mateus, Vanessa

http://hdl.handle.net/10400.21/16721

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Correction_The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf		20.19 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Resumo(s)

[This corrects the article DOI: 10.2196/38658.]

Palavras-chave

Ophthalmology Age-related macular degeneration Bevacizumab Drug therapy nAMD Neovascular age-related macular degeneration Wet macular degeneration

URI

http://hdl.handle.net/10400.21/16721

Citação

Estarreja J, Mendes P, Silva C, Camacho P, Mateus V. Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2023;12:e50411.

DOI

10.2196/50411

Coleções

ESTeSL - Artigos

Licença CC

cclicense-by-nc-nd

Métricas Alternativas

Ver registo completo